| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1110 | 23 | 1200 | 120 | 1461 | 213 | 1297 |
| ERLYTX | 75 | 1 | 52 | 6 | 73 | 12 | 73 |
| GI | 185 | 4 | 209 | 14 | 170 | 27 | 164 |
| GU | 378 | 3 | 157 | 25 | 304 | 50 | 304 |
| LEUK | 141 | 5 | 261 | 13 | 158 | 21 | 128 |
| LUNG | 203 | 5 | 261 | 26 | 317 | 46 | 280 |
| LYMPH | 390 | 9 | 470 | 38 | 463 | 73 | 444 |
| MELAN | 185 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 114 | 6 | 313 | 13 | 158 | 23 | 140 |
| MULT | 33 | 4 | 209 | 9 | 110 | 10 | 61 |
| OTHER | 50 | 2 | 104 | 6 | 73 | 11 | 67 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2866 | 62 | 3236 | 270 | 3287 | 486 | 2958 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 140 | 6 | 313 | 17 | 207 | 37 | 225 |
| ERLYTX | 13 | 1 | 52 | 5 | 61 | 5 | 30 |
| GI | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| GU | 6 | 2 | 104 | 4 | 49 | 6 | 37 |
| LEUK | 609 | 10 | 522 | 54 | 657 | 100 | 609 |
| LUNG | 365 | 8 | 417 | 39 | 475 | 78 | 475 |
| LYMPH | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| OTHER | 34 | 0 | 0 | 2 | 24 | 2 | 12 |
| PEOLC | 117 | 0 | 0 | 2 | 24 | 8 | 49 |
| PREV | 215 | 3 | 157 | 16 | 195 | 29 | 177 |
| SXQOL | 591 | 11 | 574 | 61 | 743 | 124 | 755 |
| Total | 2092 | 43 | 2243 | 202 | 2459 | 391 | 2381 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1110 | 23 | 1200 | 120 | 1461 | 213 | 1297 |
| CCD | 140 | 6 | 313 | 17 | 207 | 37 | 225 |
| ERLYTX | 88 | 2 | 104 | 11 | 134 | 17 | 103 |
| GI | 186 | 5 | 261 | 15 | 183 | 28 | 170 |
| GU | 384 | 5 | 261 | 29 | 353 | 56 | 341 |
| LEUK | 750 | 15 | 783 | 67 | 816 | 121 | 737 |
| LUNG | 568 | 13 | 678 | 65 | 791 | 124 | 755 |
| LYMPH | 391 | 10 | 522 | 39 | 475 | 74 | 450 |
| MELAN | 185 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 114 | 6 | 313 | 13 | 158 | 23 | 140 |
| MULT | 33 | 4 | 209 | 9 | 110 | 10 | 61 |
| OTHER | 84 | 2 | 104 | 8 | 97 | 13 | 79 |
| PEOLC | 117 | 0 | 0 | 2 | 24 | 8 | 49 |
| PREV | 215 | 3 | 157 | 16 | 195 | 29 | 177 |
| SXQOL | 593 | 11 | 574 | 61 | 743 | 124 | 755 |
| Total | 4958 | 105 | 5479 | 472 | 5747 | 877 | 5339 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 709 | 10 | 522 | 66 | 804 | 126 | 767 |
| ERLYTX | 42 | 0 | 0 | 3 | 37 | 6 | 37 |
| GI | 135 | 4 | 209 | 12 | 146 | 23 | 140 |
| GU | 307 | 2 | 104 | 20 | 244 | 36 | 219 |
| LEUK | 87 | 3 | 157 | 9 | 110 | 14 | 85 |
| LUNG | 130 | 4 | 209 | 17 | 207 | 32 | 195 |
| LYMPH | 257 | 4 | 209 | 26 | 317 | 53 | 323 |
| MELAN | 119 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 70 | 5 | 261 | 9 | 110 | 15 | 91 |
| MULT | 13 | 2 | 104 | 5 | 61 | 5 | 30 |
| OTHER | 50 | 2 | 104 | 6 | 73 | 11 | 67 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1921 | 36 | 1879 | 173 | 2109 | 321 | 1954 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 119 | 4 | 209 | 12 | 146 | 30 | 183 |
| ERLYTX | 13 | 1 | 52 | 5 | 61 | 5 | 30 |
| GI | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| GU | 6 | 2 | 104 | 4 | 49 | 6 | 37 |
| LEUK | 268 | 9 | 470 | 28 | 341 | 46 | 280 |
| LUNG | 225 | 6 | 313 | 21 | 256 | 43 | 262 |
| LYMPH | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| OTHER | 34 | 0 | 0 | 2 | 24 | 2 | 12 |
| PEOLC | 84 | 0 | 0 | 2 | 24 | 6 | 37 |
| PREV | 215 | 3 | 157 | 16 | 195 | 29 | 177 |
| SXQOL | 417 | 6 | 313 | 49 | 597 | 93 | 566 |
| Total | 1383 | 33 | 1722 | 141 | 1717 | 262 | 1596 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 889 | 13 | 678 | 77 | 937 | 153 | 931 |
| CCD | 150 | 6 | 313 | 20 | 244 | 36 | 219 |
| ERLYTX | 55 | 1 | 52 | 8 | 97 | 11 | 67 |
| GI | 142 | 7 | 365 | 16 | 195 | 27 | 164 |
| GU | 346 | 8 | 417 | 35 | 426 | 53 | 323 |
| LEUK | 356 | 12 | 626 | 38 | 463 | 61 | 371 |
| LUNG | 366 | 10 | 522 | 41 | 499 | 79 | 481 |
| LYMPH | 258 | 5 | 261 | 27 | 329 | 54 | 329 |
| MELAN | 119 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 69 | 5 | 261 | 9 | 110 | 15 | 91 |
| MULT | 37 | 2 | 104 | 5 | 61 | 10 | 61 |
| OTHER | 235 | 4 | 209 | 21 | 256 | 33 | 201 |
| PEOLC | 84 | 0 | 0 | 3 | 37 | 6 | 37 |
| PREV | 215 | 3 | 157 | 16 | 195 | 29 | 177 |
| SXQOL | 419 | 6 | 313 | 49 | 597 | 93 | 566 |
| Total | 3740 | 82 | 4278 | 365 | 4446 | 660 | 4018 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 926 | 19 | 991 | 110 | 1339 | 192 | 1169 |
| ERLYTX | 71 | 1 | 52 | 5 | 61 | 11 | 67 |
| GI | 109 | 2 | 104 | 8 | 97 | 17 | 103 |
| GU | 230 | 2 | 104 | 15 | 183 | 34 | 207 |
| LEUK | 109 | 5 | 261 | 12 | 146 | 19 | 116 |
| LUNG | 167 | 5 | 261 | 24 | 292 | 41 | 250 |
| LYMPH | 321 | 8 | 417 | 31 | 377 | 59 | 359 |
| MMYEL | 101 | 5 | 261 | 12 | 146 | 21 | 128 |
| MULT | 33 | 4 | 209 | 9 | 110 | 10 | 61 |
| Total | 2067 | 51 | 2660 | 226 | 2751 | 404 | 2460 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1942 | 40 | 2087 | 182 | 2216 | 336 | 2045 |
| AFFIL | 139 | 3 | 157 | 11 | 134 | 16 | 97 |
| CCOP/NCORP | 1223 | 26 | 1357 | 121 | 1473 | 231 | 1406 |
| Non-SWOG | 1653 | 35 | 1826 | 157 | 1911 | 293 | 1784 |
| Total | 4957 | 104 | 5427 | 471 | 5734 | 876 | 5332 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 0 | E | 26-MAR-26 |
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 1 | E | 26-MAR-26 |
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 2 | E | 26-MAR-26 |
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 3 | E | 26-MAR-26 |
| GU | NRGGU011 | Pros, Dbl Blinded RT +/- Androgen Dep Tx | 1 | E | 25-MAR-26 |
| OTHER | NRGGY022 | Mult Site/Stg, Carboplat Clearance Predict | 1 | E | 23-MAR-26 |
| LUNG | EA5231 | Lung, Stg II-IIIB, CheckBlock | 0 | E | 20-MAR-26 |
| LUNG | EA5231 | Lung, Stg II-IIIB, CheckBlock | 1 | E | 20-MAR-26 |
| OTHER | NRGCC014 | High Risk, Bone Meta, Radiation Tx | 1 | E | 20-MAR-26 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | T | 16-MAR-26 |
| GU | S1937 | Blad, Mets, Eribulin + Gem vs SOC | 1 | T | 13-MAR-26 |
| SXQOL | A222004 | Mult, Olanza vs Megestrol for Anorexia | 1 | E | 13-MAR-26 |
| SXQOL | EAQ211 | Lymph, Survivors, Health Disp. AYA | 1 | E | 12-MAR-26 |
| LYMPH | S2207 | LBCL, Transplant Inelig, Targeted Tx + Tafa | 1 | T | 06-MAR-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 15 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 11 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 8 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 8 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 8 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 6 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 1 | 4 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 4 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 4 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 2 | 4 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 4 |
| MMYEL | S2209 | MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| LYMPH | AHOD2131 | cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy | 2 | 3 |
| LEUK | MM1YA-S01 | AML, High Risk, Age <60, 7+3 vs experimental | 1 | 3 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 3 | 3 |
| GU | S1931 | RENAL, Stg IV, IO + Nephrectomy. vs IO Only | 1 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |